Ductal adenocarcinoma is a rare subtype of prostate cancer with a worse prognosis.Histologically, it is characterized by the presence of tall, pseudostratified columnar epithelium with abundant cytoplasm organized in a papillary or cribriform-papillary pattern. Several clinical differences distinguish this subtype of prostate cancer by the conventional acinar adenocarcinoma: exophytic growth into the prostatic urethra, different clinical presentation, different sites of metastasis and more aggressiveness. The rarity of this tumour forced to base our knowledge on small case series or on individual case reports, and does not help to establish appropriate guidelines. Therefore, the diagnosis of this tumour masks clinical implications that are still not well-understood.We report the case of a 69-year-old Caucasian man with a diagnosis of pure prostate ductal adenocarcinoma that early developed multiple metastases after radical prostatectomy. The patient started hormonal therapy with a fast biochemical and radiologic (positron emission tomography-computed tomography, PET-CT) hormonal escape. Therefore, we took the decision to perform chemotherapy with Taxotere along with prednisolone with a relative stability of prostate-specific antigen (PSA) level, but a new PET-CT scan showed a further progression of the disease. Finally, the patient underwent therapy with Abiraterone acetate that did not stop the cancer progression.No therapeutic options available showed a good control of disease progression. PSA proved to be a poor marker while, on the contrary, PET-CT scan has proved to be particularly useful in the management of the disease progression. More efforts are required to add new knowledge about this tumour and assess what is known until now.
Management and therapeutic response of a prostate ductal adenocarcinoma: a still unknown tumour? / Martorana, Eugenio; Micali, Salvatore; Pirola, Giacomo Maria; Reggiani Bonetti, Luca; Clo', Vera; Ghaith, A; Bianchi, Giampaolo. - In: UROLOGIA. - ISSN 0391-5603. - 83:3(2016), pp. 163-167.
Data di pubblicazione: | 2016 |
Data di prima pubblicazione: | 6-mag-2016 |
Titolo: | Management and therapeutic response of a prostate ductal adenocarcinoma: a still unknown tumour? |
Autore/i: | Martorana, Eugenio; Micali, Salvatore; Pirola, Giacomo Maria; Reggiani Bonetti, Luca; Clo', Vera; Ghaith, A; Bianchi, Giampaolo |
Autore/i UNIMORE: | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.5301/uro.5000174 |
Rivista: | |
Volume: | 83 |
Fascicolo: | 3 |
Pagina iniziale: | 163 |
Pagina finale: | 167 |
Codice identificativo ISI: | WOS:000393275500009 |
Codice identificativo Scopus: | 2-s2.0-85018382347 |
Codice identificativo Pubmed: | 27174534 |
Citazione: | Management and therapeutic response of a prostate ductal adenocarcinoma: a still unknown tumour? / Martorana, Eugenio; Micali, Salvatore; Pirola, Giacomo Maria; Reggiani Bonetti, Luca; Clo', Vera; Ghaith, A; Bianchi, Giampaolo. - In: UROLOGIA. - ISSN 0391-5603. - 83:3(2016), pp. 163-167. |
Tipologia | Articolo su rivista |
File in questo prodotto:
File | Descrizione | Tipologia | |
---|---|---|---|
Management and therapeutic response of a prostate ductal adenocarcinoma a still unknown tumour.pdf | Versione dell'editore (versione pubblicata) | Open Access Visualizza/Apri |

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris